Kirstin Oliveira Roster
@kroster.bsky.social
Infectious disease modeling and forecasting, global health, surveillance of drug resistance. Postdoc @ Harvard School of Public Health
Reposted by Kirstin Oliveira Roster
New publication! Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study featuring authors: @mckline98.bsky.social, @kroster.bsky.social, @dhelekal.bsky.social, @rumpl-er.bsky.social, and @yhgrad.bsky.social. Read it here at bit.ly/3Z1Zplh
Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study
Immediately introducing 2 new antibiotics to treat gonorrhea alongside 1 currently used therapy is more effective at minimizing drug resistance than holdin
bit.ly
January 9, 2026 at 3:38 PM
New publication! Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study featuring authors: @mckline98.bsky.social, @kroster.bsky.social, @dhelekal.bsky.social, @rumpl-er.bsky.social, and @yhgrad.bsky.social. Read it here at bit.ly/3Z1Zplh
Reposted by Kirstin Oliveira Roster
U.S. gonorrhea rates fell in 2022 and 2023 after nearly a decade of increases—new paper by @kroster.bsky.social and @yhgrad.bsky.social maps out possible drivers, current evidence, and the data needed to understand what is causing the decline. Read more at bit.ly/4aWmc9i
Why are gonorrhea case rates declining in the US? A research agenda - PubMed
After nearly a decade of rising gonorrhea rates, the United States CDC reported a decline in infection rates for two years in a row in 2022 and 2023, especially among young adults. While this warrants cautious optimism that control measures have been successful, the reasons for the decline are unkno …
bit.ly
December 18, 2025 at 4:52 PM
U.S. gonorrhea rates fell in 2022 and 2023 after nearly a decade of increases—new paper by @kroster.bsky.social and @yhgrad.bsky.social maps out possible drivers, current evidence, and the data needed to understand what is causing the decline. Read more at bit.ly/4aWmc9i
Reposted by Kirstin Oliveira Roster
⚠️ New preprint ⚠️: Two new antibiotics are likely coming for gonorrhea 💊. How should we deploy them in the US to minimize drug resistance? @kroster.bsky.social @dhelekal.bsky.social Eva Rumpler @yhgrad.bsky.social [1/10]
www.medrxiv.org/content/10.1...
www.medrxiv.org/content/10.1...
Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study
Introduction Drug resistance in Neisseria gonorrhoeae is an urgent public health threat. The anticipated approval of two new antimicrobials for gonorrhea prompts the need for evidence-based rollout st...
www.medrxiv.org
July 3, 2025 at 3:29 PM
⚠️ New preprint ⚠️: Two new antibiotics are likely coming for gonorrhea 💊. How should we deploy them in the US to minimize drug resistance? @kroster.bsky.social @dhelekal.bsky.social Eva Rumpler @yhgrad.bsky.social [1/10]
www.medrxiv.org/content/10.1...
www.medrxiv.org/content/10.1...
New preprint. After years of increases, gonorrhea diagnosis rates dropped in the US in 2022 and 2023. While the news is promising, understanding WHY is key to sustaining progress.
dash.harvard.edu/handle/1/427...
dash.harvard.edu/handle/1/427...
Why are gonorrhea diagnoses declining in the US?
After a decade of rising cases, the US CDC reported a decline in the rate of gonorrhea diagnoses for two years in a row in 2022 and 2023, especially among young adults. Primary and secondary syphilis ...
dash.harvard.edu
May 21, 2025 at 5:29 PM
New preprint. After years of increases, gonorrhea diagnosis rates dropped in the US in 2022 and 2023. While the news is promising, understanding WHY is key to sustaining progress.
dash.harvard.edu/handle/1/427...
dash.harvard.edu/handle/1/427...
Reposted by Kirstin Oliveira Roster
In our new paper in PLOS Neglected Tropical Diseases, we quantified the gap between expected and observed dengue cases in Brazil. We used an interrupted time series approach, incorporating predictions generated by machine learning models. With @kroster.bsky.social
journals.plos.org/plosntds/art...
journals.plos.org/plosntds/art...
January 6, 2025 at 11:52 PM
In our new paper in PLOS Neglected Tropical Diseases, we quantified the gap between expected and observed dengue cases in Brazil. We used an interrupted time series approach, incorporating predictions generated by machine learning models. With @kroster.bsky.social
journals.plos.org/plosntds/art...
journals.plos.org/plosntds/art...
Reposted by Kirstin Oliveira Roster
Now published in AJE: academic.oup.com/aje/advance-...
December 15, 2024 at 12:45 AM
Now published in AJE: academic.oup.com/aje/advance-...
New preprint: Drug resistant gonorrhea is a big public health problem. Resistance to ceftriaxone, the last approved antibiotic, is spreading globally. When we first detect one of these very resistant isolates, how many undetected cases are there likely to be? www.medrxiv.org/content/10.1...
Estimating the undetected burden of infections and the likelihood of strain persistence of drug-resistant Neisseria gonorrhoeae
Antimicrobial resistance (AMR) is a serious public health threat. Neisseria gonorrhoeae has developed resistance to all antibiotics recommended for treatment and reports of reduced susceptibility to c...
www.medrxiv.org
November 27, 2024 at 12:44 AM
New preprint: Drug resistant gonorrhea is a big public health problem. Resistance to ceftriaxone, the last approved antibiotic, is spreading globally. When we first detect one of these very resistant isolates, how many undetected cases are there likely to be? www.medrxiv.org/content/10.1...